The specific objectives of this study are to investigate the (1) feasibility, (2) preliminary effectiveness and (3) effect sizes of the integrated smoking cessation and alcohol intervention when compared to standalone smoking cessation (ST) and control among young adults in Hong Kong.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Enrollment
150
participants who are ready to quit smoking: a brief smoking cessation intervention based on the "5A" models and "STAR" method as quitting skills. participants who are not yet ready to quit smoking: a brief smoking cessation intervention based on the "5R" models.
brief advice on alcohol use based on the "FRAMES" model and the brief smoking cessation intervention based on the "5A" and "5R" models.
The Hong Kong Polytechnic University
Hong Kong, Hong Kong, Hong Kong
screening rate
the number of smokers screened divided by the number of smokers available for screening
Time frame: From screening to the end of treatment after 6 months
eligibility rate
the number of eligible smokers divided by the number of screened people
Time frame: From screening to the end of treatment after 6 months
consent rate
the number of eligible smokers who agree to participate divided by the number of eligible smokers
Time frame: From screening to the end of treatment after 6 months
randomization rate
the number of participants who are randomized divided by the number of eligible smokers who consent to participate
Time frame: From screening to the end of treatment after 6 months
attendance rate
the number of participants who complete the intervention divided by the number of participants who are randomized into the treatment arms (ST and II)
Time frame: From screening to the end of treatment after 6 months
adherence to intervention
the number of participants in the two treatment arms who practice the skills learned during the intervention divided by the number of participants in the two treatment arms
Time frame: From screening to the end of treatment after 6 months
retention rate
the number of participants who remain in the study divided by the number of participants randomized
Time frame: From screening to the end of treatment after 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
completion rate
the number of participants who complete the questionnaire divided by the number of questionnaires distributed
Time frame: From screening to the end of treatment after 6 months
missing data
the percentage of missing data
Time frame: From screening to the end of treatment after 6 months
adverse events
unfavorable or unintended events during the study period that were not present at baseline or appear to have worsened since baseline
Time frame: From screening to the end of treatment after 6 months
Smoking quit rate
the effect size of II on self-reported and biochemically validated quit rates for smoking at 6 months relative to ST and Control.
Time frame: From screening to the end of treatment after 6 months
alcohol quit rate
the effect size of II on self-reported quit rate for alcohol at 6 months relative to ST and Control
Time frame: From screening to the end of treatment after 6 months